14Dec 2022
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms

Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms

Contemporary data on infections after intensive chemotherapy for acute myeloid leukemia (AML) are scarce. Cladribine, high-dose cytarabine, G-CSF, and dose-escalated mitoxantrone (“CLAG-M”) may result in higher remission rates than standard-dose cytarabine plus anthracyclinebut may result in more infections. Bacterial bloodstream infections were the most frequent, followed by respiratory tract infections. These data indicate that infections continue to cause substantial morbidity in patients treated for AML, especially those treated for relapsed/refractory disease, and are more common with newer, more myelosuppressive regimens such as CLAG-M. Therefore, improved strategies for infection prevention are needed.

  • #oncology

Like

Save

Share